Xueting Ren
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 14, 2025
Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL.
Journal: International immunopharmacology
Published: July 28, 2025
A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma.
Journal: Annals of medicine
Published: May 07, 2025
Bisecting GlcNAc enhances CD8+ T cell-mediated killing of breast cancer by suppressing PD-L1 expression and its binding to PD-1.
Journal: Experimental hematology & oncology
Published: December 25, 2024
Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-β1-driven macrophage polarization in myeloid leukemias.
Journal: Haematologica
Published: December 03, 2024
Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis.
Journal: Cell communication and signaling : CCS
Published: November 29, 2024
Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 11, 2024
Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
Journal: Journal of cancer research and clinical oncology
Published: May 09, 2024
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 01, 2024
Bisecting GlcNAc modification reverses the chemoresistance via attenuating the function of P-gp.
Journal: Theranostics
Published: January 04, 2024
Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy.
Journal: International journal of biological sciences
Published: January 02, 2024
Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.
Journal: Clinical breast cancer
Published: September 19, 2023
Last Updated: 09/26/2026